Enhanced intracellular delivery of a model drug using microbubbles produced by a microfluidic device.
Enhanced intracellular delivery of a model drug using microbubbles produced by a microfluidic device.
复制标题
DOI:
10.1016/j.ultrasmedbio.2013.01.023
复制
发表时间:
2013-07
影响因子:
2.9
通讯作者:
Hossack, John A.
中科院分区:
文献类型:
--
作者:
Dixon, Adam J.;Dhanaliwala, Ali H.;Chen, Johnny L.;Hossack, John A.
关键词:
Focal drug delivery to a vessel wall facilitated by intravascular ultrasound and microbubbles holds promise as a potential therapy for atherosclerosis. Conventional methods of microbubble administration result in rapid clearance from the blood stream and significant drug loss. To address these limitations, we evaluated whether drug delivery could be achieved with transiently stable microbubbles produced in real-time and in close proximity to the therapeutic site. Rat aortic smooth muscle cells were placed in a flow chamber designed to simulate physiological flow conditions. A flow-focusing microfluidic device (FFMD) produced 8 μm diameter monodisperse microbubbles within the flow chamber, and ultrasound was applied to enhance uptake of a surrogate drug (calcein). Acoustic pressures up to 300 kPa and flow rates up to 18 mL/s were investigated. FFMD generated microbubbles were stabilized with a polyethylene glycol-40 stearate shell and had either a perfluorobutane (PFB) or nitrogen gas core. The gas core composition affected stability, with PFB and nitrogen microbubbles exhibiting half-lives of 40.7 and 18.2 seconds, respectively. Calcein uptake was observed at lower acoustic pressures with nitrogen microbubbles (100 kPa) than with PFB microbubbles (200 kPa) (p < 0.05, n ≥ 3). In addition, delivery was observed at all flow rates, with maximal delivery (> 70% of cells) occurring at a flow rate of 9 mL/s. These results demonstrate the potential of transiently stable microbubbles produced in real-time and in close proximity to the intended therapeutic site for enhancing localized drug delivery.
登录
查看更多内容
DOI:
10.1109/tbme.2009.2034533
发表时间:
2010-01
期刊:
IEEE transactions on bio-medical engineering
影响因子:
--
作者:
Choi JJ;Feshitan JA;Baseri B;Wang S;Tung YS;Borden MA;Konofagou EE
通讯作者:
Konofagou EE
影响因子:
3.3
作者:
BUTLER, BD;HILLS, BA
通讯作者:
HILLS, BA
影响因子:
2.4
作者:
Guzmán, HR;Nguyen, DX;Prausnitz, MR
通讯作者:
Prausnitz, MR
影响因子:
2.4
作者:
JENSEN, JA
通讯作者:
JENSEN, JA
DOI:
10.1046/j.1540-8175.2002.00229.x
发表时间:
2002-04-01
影响因子:
1.5
作者:
de Jong, N;Bouakaz, A;Frinking, P
通讯作者:
Frinking, P